(CTIC) Community Analysis from
Bulls REASONS TO BUY
|
89%
agree
29 votes
|
CTIC continues upward trend |
Bears REASONS TO SELL
|
71%
agree
7 votes
|
Waiting for FDA |
|
60%
agree
5 votes
|
ctic fluk |
|
0%
agree
0 votes
|
Lawsuits |
May 25, 2013
(Value Investing,
5/1/12)
Stock symbols are the cornerstone of the stock market and a pure source of identity for companies. Billions of investment dollars change hands every day based on those little...(read more)
(Stock Blog Hub,
10/13/11)
In late September, Cell Therapeutics (CTIC) announced that a second independent radiologic review of data from the pivotal trial PIX301 of lead drug pixantrone for aggressive...(read more)
(Penny Stock DD,
10/4/11)
It's more than seven years since Cell Therapeutics Inc.'s (CTIC: News ) lead cancer drug Pixantrone has been under development. Rejected by the FDA in April 2010 after the...(read more)
Cell Therapeutics (CTIC) Company Overview
There is no analysis for CTIC yet. But you can go to Wikinvest to help create one!
